A detailed history of Capitolis Liquid Global Markets LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Capitolis Liquid Global Markets LLC holds 492,600 shares of JNJ stock, worth $72.1 Million. This represents 0.85% of its overall portfolio holdings.

Number of Shares
492,600
Previous 129,800 279.51%
Holding current value
$72.1 Million
Previous $19 Billion 320.79%
% of portfolio
0.85%
Previous 0.23%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$145.48 - $167.38 $52.8 Million - $60.7 Million
362,800 Added 279.51%
492,600 $79.8 Billion
Q2 2024

Aug 13, 2024

SELL
$144.38 - $157.78 $72.2 Million - $78.9 Million
-500,000 Reduced 79.39%
129,800 $19 Billion
Q1 2024

May 13, 2024

BUY
$155.22 - $162.74 $20.1 Million - $21.1 Million
129,800 Added 25.96%
629,800 $99.6 Billion
Q4 2023

Feb 14, 2024

BUY
$145.6 - $158.88 $72.8 Million - $79.4 Million
500,000 New
500,000 $78.4 Billion

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $383B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Capitolis Liquid Global Markets LLC Portfolio

Follow Capitolis Liquid Global Markets LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capitolis Liquid Global Markets LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capitolis Liquid Global Markets LLC with notifications on news.